Pharmsynthez buys Kevelt to grow in Europe

26-Jan-2011 - Russian drugmaker Pharmsynthez has bought Estonian manufacturer Kevelt in a bid to expand its international business.

Euticals to buy Archimica to expand manufacturing base

18-Jan-2011 - Italy-based API maker Euticals will buy fine chemicals firm Archimica from investment group TowerBrook Capital Partners.

New deals in the German drug packaging sector

13-Jan-2011 - Expansion has been a theme for German pharmaceutical packaging firms of late with the acquisition of Seidenader Maschinenbau by the Kober Group following just weeks after Edelmann bought a stake in Hungary’s Zalai Nyomda

Genzyme lowers guidance after Fabrazyme production delay

13-Jan-2011 - Genzyme has lowered 2011 financial projections after delaying the date it expects Fabrazyme production to return to normal.

Sun set on buying NextPharma and expanding it through acquisitions

12-Jan-2011 - NextPharma Technologies will be bought by Sun European Partners, the European adviser to US investment group Sun Capital Partners, in a deal announced late yesterday.

Aurobindo to sell Chinese ingredient unit to Sinopharm

11-Jan-2011 - Aurobindo Pharma is to sell its Chinese unit to Sinopharm as part of a strategic shift from low-margin ingredients to more profitable formulations.

Latest M&As in the pharmaceutical space

04-Jan-2011 - in-Pharmatechnologist presents a roundup of the latest deals and acquisitions in the pharmaceutical sector with news from Optima, SPI and DPS Engineering.

Top 5 biopharm cutback and closure articles of 2010

21-Dec-2010 - Big pharma continued to cut in 2010, closing plants and laying off staff in an attempt to cut costs and adjust post-merger. in-PharmaTechnologist presents a round up of five of the most read in 2010.

Aesica buys UCB plants and signs long-term supply deal

20-Dec-2010 - Aesica has bought three manufacturing sites from UCB, making its first foray into continental Europe and more than doubling its production capacity.

SurModics mulls pharma biz sale

15-Dec-2010 - SurModics said it may sell its pharmaceutical unit to focus on its medical device platform, I-vation delivery system and diagnostics businesses.

News in brief

Reckitt Benckiser buys Paras

14-Dec-2010 - Reckitt Benckiser said it will pay INR32.6bn for Indian drugmaker Paras Pharmaceuticals to build its position in the consumer healthcare sector.

News in brief

J&J bids EUR1.75bn for Crucell

09-Dec-2010 - US healthcare major J&J has launched a bid for Nertherlands-based Crucell, manufacturer of the PER.C6 biomanufacturing cell line.

News in brief

GSK rumoured to be close to buying Nanjing MeiRui Pharma

06-Dec-2010 - GSK is close to buying Chinese-based specialist urology drugmaker Nanjing MeiRui Pharma according to various reports.

Cardinal Health acquires Chinese distributer as part of new ‘growth platform’

01-Dec-2010 - US based healthcare distributer, Cardinal Health, has announced the $470m acquisition of privately held healthcare distribution business Zuellig Pharma China, known locally as Yong Yu.

GSK to sell penicillin factory to Dr Reddy’s

25-Nov-2010 - GlaxoSmithKline will sell its oral penicillin manufacturing facility in Tennessee, US, to Dr Reddy’s for an undisclosed sum, along with US rights to its Augmentin and Amoxin brands.

News in brief

Camlin Fine Chemicals’ board of directors OK Italian acquisition

24-Nov-2010 - Camlin Fine Chemicals has been given the green light from its board of directors to acquire an unnamed Italian fine chemicals manufacturer and form a subsidiary company to help boost its presence in the Middle East.

Genzyme looks at bids based on Campath performance in MS

23-Nov-2010 - Rumours suggest that Genzyme would consider accepting lower value takeover bids that take into account future performance of its cancer drug Campath in MS indications.

Roche to slash 4,800 jobs worldwide

18-Nov-2010 - Roche will cut 4,800 jobs worldwide over the next two years as part of a restructuring program designed to slash $2.4bn Swiss francs ($2.4bn) from annual costs.

Lilly buys Avid to boost diagnostics and AD biz

10-Nov-2010 - US drugmaker Eli Lilly said it will buy Avid Radiopharmaceuticals to expand its neuroscience diagnostics business.

AMRI posts loss, but forecasts 23% contract rev growth in Q4

10-Nov-2010 - API maker AMRI cited arbitration costs, efforts to address a US FDA warning letter and acquisitions as key factors in Q3 loss, but predicted that large-scale contract manufacturing business will drive final quarter gains.

News in brief

Endo's takeover of Penwest gets shareholder approval

08-Nov-2010 - Penwest Pharmaceuticals shareholders have voted in favour of Endo Pharmaceuticals takeover plan, paving the way for the $144m merger.

ATMI acquires Artelis in ‘disposables’ deal

04-Nov-2010 - ATMI has acquired Artelis, a Belgian biotech firm, in an effort to “get closer to customers” by widening its disposable technology portfolio to the life sciences research and manufacturing sector.

Hikma builds in US injectables sector with Baxter unit buy

02-Nov-2010 - Baxter International will sell its US generic injectables business to UK-based manufacturer Hikma Pharmaceuticals

News in brief

Genzyme values itself at $22.7bn, $20 per share higher than Sanofi bid

25-Oct-2010 - US Biotechnology firm Genzyme predicts 2011 earnings in $4.30 to $4.60 range, which would make it worth $89 per share or $22.7bn.